Abstract: A body mount for use in motor vehicles in which the mount is sandwiched between the subframe and body. The mount has an insert member with an oblong shape in the lateral displacement direction of the vehicle. The insert member is surrounded by a microcellular urethane body. The oblong shape increases the compression of the microcellular urethane body that can be used to respond to lateral forces. The lateral response rate can be stiffer than the fore and aft response rate. The isolation mount also can facilitate fine tuning thereof by selectively indenting a cup member surrounding the microcellular urethane body to adjust the vibration characteristics of the body mount.

Abstract: In order to protect a software program, at least one corruption function is included in the program. Also included in the program is at least one instruction that causes the program to be directed to the corruption function. An available breakpoint is then set such that, when the starting location of the corruption function is reached, an exception is generated and the handling of the exception causes the corruption function not to run. This has the effect that, if a malicious user attempts to use the available hardware breakpoint to perform unauthorized actions on the software program, the corruption function will run, and the software program will be unusable.

Abstract: There is disclosed a container for receiving and sealing material in an internal cavity. The container is configured to be shiftable about an intermediate hinge portion and provides a dispensation port defined by a frangible connected panel of the container. The panel can be reclosed after initial severing of the frangible connection upon initial opening.

Abstract: A method of source code instrumentation for computer program performance profiling includes generating (14) and inserting (19) instrumentation code around a call site of a child function in a parent function. The instrumentation code may use a reference to an unique instrumentation record (13), such as a timing record. The instrumentation code may be optimised (15) to use the exit time of a preceding call site in the parent function as the entry time of the call site. It may be inserted depending on the level in the call hierarchy of the child function and its execution at run time may depend on the state of an enable flag, which can be set via a viewing interface. Two versions of the child function may be generated (18), one being instrumented and other being non-instrumented and which one is run depends on the enable flag.

Abstract: In order to protect a software program, at least one corruption function is included in the program. Also included in the program is at least one instruction that causes the program to be directed to the corruption function. An available breakpoint is then set such that, when the starting location of the corruption function is reached, an exception is generated and the handling of the exception causes the corruption function not to run. This has the effect that, if a malicious user attempts to use the available hardware breakpoint to perform unauthorized actions on the software program, the corruption function will run, and the software program will be unusable.

Abstract: An implementation tool for generating an implementation of a first data structure, wherein the first data structure comprises a plurality of linked structural components, and wherein the first data structure represents meaningful components of a given system and a parent set of interrelationships between those meaningful components, the tool comprising: first-data-structure input means, operable to receive a said first data structure, or a description thereof; and processing means operable to generate an implementation of the received first data structure, the implementation comprising: a second data structure, or a description thereof, corresponding to said first data structure, wherein said second data structure is defined by a subset of the parent set of interrelationships; and implementation rules which allow the parent set of interrelationships to be enforced during a subsequent processing operation which utilises said implementation.

Abstract: The present invention relates to a system for measuring the level of granular material in a container immersed in an aqueous medium, particularly, but not exclusively, for use as a measure of sanitizer level in spa and whirlpool halogenation systems. Electrodes fixed in the container wall are used to measure the electrical conductance along a path which is part filled with the granular material. Coils of wire are arranged such that the interrogating signal is coupled inductively to the sensor head. In this way the granule container can be made demountable, with no bare conductor material exposed to the aqueous medium. A separate reference circuit is used to measure the conductivity of the water in the system, and this signal is used to normalize the signal obtained from inside the container.

Abstract: A dental contact adjustment tool. The novel dental tool includes a handle and a support structure for coupling a marking apparatus to the handle such that the marking apparatus is at an angle appropriate for delivering a marking medium to an interproximal area of a tooth. In an illustrative embodiment, the support structure includes an angled shaft having a first end coupled to the handle and a second end coupled to a retaining mechanism for holding the marking apparatus at a substantially right angle to the shaft. The marking medium is a transferable medium that will transfer from a tooth to an artificial crown upon contact. In the illustrative embodiment, the marking medium is graphite, and the marking apparatus includes a solid piece of graphite held by a retaining body adapted to interface with the retaining mechanism of the support structure.

Abstract: The present invention provides methods and compositions for increasing the susceptibility of PDF inhibitors against Gram-negative organisms by using efflux pump inhibitors.

Abstract: In a biological measurement system (10) for collecting one or more samples of sputum and/or mucus from a patient in the form of an aerosol and for analyzing said one or more samples to detect whether or not pathogens are present therein, the one or more samples are in solution within the system (10) and detection of the pathogens is performed using a fluorescently labeled assay. The system (10) is adapted to detect bacterial pathogens using evanescent-wave spectroscopy preferably by using a single-reflective technique. The one or more samples are advantageously provided to the system (10) in aerosol form. However, the system (10) is capable of being adapted for use in analyzing samples in liquid form. Methods of analyzing said one or more samples in the system (10) are described.

Abstract: A method for detecting an imperfection in a blister package having at least one radiation-transmissible layer, optionally moving, the blister package having a flat side and a pocket side, the method comprising the steps of directing radiation at the flat side and/or the pocket side of the blister package and detecting any radiation emitted from at least one edge of the blister package.

Abstract: The present invention relates to a system for measuring the level of granular material in a container immersed in an aqueous medium, particularly, but not exclusively, for use as a measure of sanitizer level in spa and whirlpool halogenation systems. Electrodes fixed in the container wall are used to measure the electrical conductance along a path which is part filled with the granular material. Coils of wire are arranged such that the interrogating signal is coupled inductively to the sensor head. In this way the granule container can be made demountable, with no bare conductor material exposed to the aqueous medium. A separate reference circuit is used to measure the conductivity of the water in the system, and this signal is used to normalize the signal obtained from inside the container.

Abstract: Synergistic combinations of a squalene epoxidase inhibitor such as terbinafine and a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro, 33-desoxyascomycin are provided, which are useful in particular in the treatment of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g. the skin plays a role, such as atopic dermatitis and seborrhoeic dermatitis, and in situations of fungal resistance.

Abstract: In a biological measurement system (10) for collecting one or more samples of sputum and/or mucus from a patient in the form of an aerosol and for analysing said one or more samples to detect whether or not pathogens are present therein, the one or more samples are in solution within the system (10) and detection of the pathogens is performed using a fluorescently labeled assay. The system (10) is adapted to detect bacterial pathogens using evanescent-wave spectroscopy preferably by using a single-reflective technique. The one or more samples are advantageously provided to the system (10) in aerosol form. However, the system (10) is capable of being adapted for use in analysing samples in liquid form. Methods of analysing said one or more samples in the system (10) are described.

Abstract: Synergistic combinations of a squalene epoxidase inhibitor such as terbinafine and a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro, 33-desoxyascomycin are provided, which are useful in particular in the treatment of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g. the skin plays a role, such as atopic dermatitis and seborrhoeic dermatitis, and in situations of fungal resistance.

Abstract: Use of a combination of the squalene epoxidase inhibitor terbinafine and an azole 14-alpha-methyldemethylase inhibitor (fluconazole or itraconazole) in mycotic infections caused by azole-resistant fungal strains, and corresponding pharmaceutical compositions, process and method.

Abstract: Use of compounds of formula (I), wherein R has various significances, in free base form or in pharmaceutically acceptable salt form, as agents against H. pylori infection and associated diseases.